These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16928133)

  • 1. Differences in binding sites of two melatonin receptors help to explain their selectivity to some melatonin analogs: a molecular modeling study.
    Chugunov AO; Farce A; Chavatte P; Efremov RG
    J Biomol Struct Dyn; 2006 Oct; 24(2):91-107. PubMed ID: 16928133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling of human MT2 melatonin receptor: the role of Val204, Leu272 and Tyr298 in ligand binding.
    Mazna P; Obsilova V; Jelinkova I; Balik A; Berka K; Sovova Z; Ettrich R; Svoboda P; Obsil T; Teisinger J
    J Neurochem; 2004 Nov; 91(4):836-42. PubMed ID: 15525337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homology modeling of MT1 and MT2 receptors.
    Farce A; Chugunov AO; Logé C; Sabaouni A; Yous S; Dilly S; Renault N; Vergoten G; Efremov RG; Lesieur D; Chavatte P
    Eur J Med Chem; 2008 Sep; 43(9):1926-44. PubMed ID: 18255198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New ligands at the melatonin binding site MT(3).
    Boussard MF; Truche S; Rousseau-Rojas A; Briss S; Descamps S; Droual M; Wierzbicki M; Ferry G; Audinot V; Delagrange P; Boutin JA
    Eur J Med Chem; 2006 Mar; 41(3):306-20. PubMed ID: 16414149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bivalent ligand approach on N-{2-[(3-methoxyphenyl)methylamino]ethyl}acetamide: synthesis, binding affinity and intrinsic activity for MT(1) and MT(2) melatonin receptors.
    Spadoni G; Bedini A; Orlando P; Lucarini S; Tarzia G; Mor M; Rivara S; Lucini V; Pannacci M; Scaglione F
    Bioorg Med Chem; 2011 Aug; 19(16):4910-6. PubMed ID: 21775151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3.
    Leclerc V; Ettaoussi M; Rami M; Farce A; Boutin JA; Delagrange P; Caignard DH; Renard P; Berthelot P; Yous S
    Eur J Med Chem; 2011 May; 46(5):1622-9. PubMed ID: 21377769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of human Orexin-1 and -2 G-protein-coupled receptors with novel and published antagonists by modeling, molecular dynamics simulations, and site-directed mutagenesis.
    Heifetz A; Morris GB; Biggin PC; Barker O; Fryatt T; Bentley J; Hallett D; Manikowski D; Pal S; Reifegerste R; Slack M; Law R
    Biochemistry; 2012 Apr; 51(15):3178-97. PubMed ID: 22448975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rhodopsin-based model for melatonin recognition at its G protein-coupled receptor.
    Navajas C; Kokkola T; Poso A; Honka N; Gynther J; Laitinen JT
    Eur J Pharmacol; 1996 May; 304(1-3):173-83. PubMed ID: 8813600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models.
    Rivara S; Lorenzi S; Mor M; Plazzi PV; Spadoni G; Bedini A; Tarzia G
    J Med Chem; 2005 Jun; 48(12):4049-60. PubMed ID: 15943478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design.
    Gloriam DE; Foord SM; Blaney FE; Garland SL
    J Med Chem; 2009 Jul; 52(14):4429-42. PubMed ID: 19537715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists.
    Zlotos DP; Attia MI; Julius J; Sethi S; Witt-Enderby PA
    J Med Chem; 2009 Feb; 52(3):826-33. PubMed ID: 19193160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
    Bissantz C; Bernard P; Hibert M; Rognan D
    Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
    Axe FU; Bembenek SD; Szalma S
    J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of two different melatonin binding sites in peripheral tissues of the teleost Tinca tinca.
    López Patiño MA; Guijarro AI; Alonso-Gómez AL; Delgado MJ
    Gen Comp Endocrinol; 2012 Jan; 175(1):180-7. PubMed ID: 22134177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationship of novel benzoxazole derivatives as melatonin receptor agonists.
    Sun LQ; Chen J; Bruce M; Deskus JA; Epperson JR; Takaki K; Johnson G; Iben L; Mahle CD; Ryan E; Xu C
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3799-802. PubMed ID: 15203165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are G protein-coupled receptor heterodimers of physiological relevance?--Focus on melatonin receptors.
    Levoye A; Jockers R; Ayoub MA; Delagrange P; Savaskan E; Guillaume JL
    Chronobiol Int; 2006; 23(1-2):419-26. PubMed ID: 16687315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Acetyl-5-arylalkoxytryptamine analogs: probing the melatonin receptors for MT(1) -selectivity.
    Markl C; Clafshenkel WP; Attia MI; Sethi S; Witt-Enderby PA; Zlotos DP
    Arch Pharm (Weinheim); 2011 Oct; 344(10):666-74. PubMed ID: 21887801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based identification of binding sites, native ligands and potential inhibitors for G-protein coupled receptors.
    Cavasotto CN; Orry AJ; Abagyan RA
    Proteins; 2003 May; 51(3):423-33. PubMed ID: 12696053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel quantitative structure-activity relationship method to predict the affinities of MT3 melatonin binding site.
    Du H; Wang J; Zhang X; Hu Z
    Eur J Med Chem; 2008 Dec; 43(12):2861-9. PubMed ID: 18400335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand binding to the human MT2 melatonin receptor: the role of residues in transmembrane domains 3, 6, and 7.
    Mazna P; Berka K; Jelinkova I; Balik A; Svoboda P; Obsilova V; Obsil T; Teisinger J
    Biochem Biophys Res Commun; 2005 Jul; 332(3):726-34. PubMed ID: 15913560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.